Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$26.25 – $83.86
77% from low
Borrow rate
15.57%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2023 | 2024 | |
|---|---|---|
| Revenue | $0 | $0 |
| Cost of revenue | $0 | $0 |
| Gross profit | $0 | $0 |
| Gross margin | — | — |
| R&D | $15.6M | $107.5M |
| Operating income | −$43.7M | −$224.8M |
| EBITDA | −$47.2M | −$218.2M |
| Net income | −$47.2M | −$209.1M |
| Net margin | — | — |
| EPS (diluted) | -0.95 | -2.03 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $0 | $-3.42 | $-3.72–$-3.12 | 2 |
| 2027 | $0 | $-4.08 | $-4.66–$-3.51 | 2 |
| 2028 | $55M | $-3.80 | $-3.80–$-3.80 | 1 |
| 2029 | $394M | $-4.92 | $-4.92–$-4.92 | 1 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds MTSR.
No tracked institution reports a position in MTSR as of their last filing.
No one on the platform has traded MTSR yet.
| $12.6B |
| — |
| CRSPCRISPR Therapeutics AG | $55.45 | -1.60% | $5.3B | — |
| CYTKCytokinetics, Incorporated | $86.15 | -1.27% | $10.7B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
@AStrokeOfLuck $LLY remember @judgeyoung2 $PFE rather pay $10 billion for $MTSR , than 5-$6 billion for $VKTX or chump change for $ALT says it all. 🤭🫡😅👇
View on StockTwits ↗$VKTX holding onto vs $MTSR in 2025. In 1 year you could of got a 207% gain but settled for 7%.
View on StockTwits ↗@bavariaron wonder if he pushed for $PFE to overpay for an inferior asset in $MTSR. So strange they’d put all their marbles on a single agonist small molecule. Higher risk, lower efficacy.
View on StockTwits ↗$GPCR Doesn't look like the market priced it in, but I do like the hire of former $MTSR Chief Legal Officer. I think this is a strong move. While I think previous company ties are often over inflated, this hire appears very pertinent to what $GPCR needs at this point. A snippet from the Structure Press Release: "Mr. Lang most recently served as Chief Legal Officer and Secretary at Metsera, Inc., helping to guide the company through its up to $10 billion acquisition by Pfizer. Prior to Metsera, Mr. Lang served as Chief Business and Legal Officer at Lyell Immunopharma, Inc., and held several executive officer positions at Myovant Sciences, where he helped lead the company through Phase 3 clinical development, global approval and commercialization of Myfembree® and Orgovyx®." Welcome aboard Mr. Lang! https://ir.structuretx.com/news-releases/news-release-details/structure-therapeutics-appoints-matthew-lang-jd-chief-operating
View on StockTwits ↗$NMRA Old article. But goes to show Berns has been through big $$$ acquirerors before. I can only hope a bidding war ensues for us like it did $MTSR. https://endpoints.news/exclusive-the-inside-story-of-pfizer-and-novos-fight-for-the-10b-metsera-deal/
View on StockTwits ↗$VERU Haven't forgotten about you. Keep preserving that muscle and let's get a damn deal done! Here are some highlights from the upcoming "4th Obesity & Weight Loss Drug Development Summit." (July 14th-16) The summit specifically highlights $VERU in the same bullets as $NVO, $LLY and $RHHBY and calling them "Innovative Biotech" along with Canary and $MTSR For those interested, here's the link to the Summit and downloading the Agenda is free with this link: Summit Link: https://obesity-weight-loss-summit.com/?utm_source=marketo&utm_medium=email&utm_campaign=primary&utm_content=launch/ev-69725/em-01 Event Guide Link: https://obesity-weight-loss-summit.com/full-event-guide/?utm_source=marketo&utm_medium=email&utm_campaign=primary&utm_content=launch/ev-69725/em-01
View on StockTwits ↗$BTC.X $MTSR IM HEATING YOUR HOME! 🩳 🔥
View on StockTwits ↗MoonLake Stock Soars As Biotech Fund Reloads, Takeover Chatter Ignites $MLTX $MTSR $PRAX $BBIO $EWTX https://stocktwits.com/news/equity/markets/moon-lake-stock-soars-as-biotech-fund-reloads-takeover-chatter-ignites/cZR0WqyR4Hi
View on StockTwits ↗$GOOGL $GOOG Sold off their $MTSR Metsera stake today after the $PFE acquisition. Netted them a cool 500 million $. Talk about investing chops. Google Ventures is so cracked that Google’s P/E ratio with/without their investment in other companies is like 6 apart.
View on StockTwits ↗$NMRA A VERY sizeable amount of $2.50 April CALLS have been traded today. Interesting since this is before Navacaprant KOASTAL 2/3 date is supposed to be announced. $NVO $PFE $MTSR $LLY Maybe NLRP 3 obesity update?
View on StockTwits ↗$BTC.X $MTSR NUMBER GO DOWN, I BOUGHT, WENT DOWN MORE, I BOUGHT MORE, NOW ITS TIME FOR NUMBER GO UP!
View on StockTwits ↗$NMRA $PFE $MTSR weight loss drug data was meh. Let's hope Pinto (was board member of $MTSR) has a better outcome with ours. One less competitor to be worried about.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.